Estrogen-induced pancreatitis after discontinuation of concomitant medroxyprogesterone therapy.
Isley
W L
WL
University of Missouri-Kansas City School of Medicine, USA.
Oki
J
J
D003280:Contraceptives, Oral, Synthetic / Q000008:administration & dosage*; D015914:Estrogen Replacement Therapy / Q000009:adverse effects*; D004966:Estrogens, Conjugated (USP) / Q000009:adverse effects*; D005260:Female; D006801:Humans; D015228:Hypertriglyceridemia / Q000097:blood; D008055:Lipids / Q000097:blood; D008525:Medroxyprogesterone / Q000008:administration & dosage*; D008875:Middle Aged; D010195:Pancreatitis / Q000139:chemically induced*
D003280:Contraceptives, Oral, Synthetic; D004966:Estrogens, Conjugated (USP); D008055:Lipids; D008525:Medroxyprogesterone